A randomized, three-phase crossover study evaluating the pharmacokinetic interaction of atorvastatin and fixed-dose combination of sofosbuvir/ledipasvir in healthy male Egyptian volunteers
Latest Information Update: 07 Apr 2021
At a glance
- Drugs Atorvastatin (Primary) ; Ledipasvir/sofosbuvir (Primary) ; Ledipasvir; Paracetamol; Sofosbuvir
- Indications Cardiovascular disorders; Heart failure; Hepatic-porphyria; Hepatitis B; Hepatitis C; Hypercholesterolaemia; Hyperlipoproteinaemia type IIa; Hyperlipoproteinaemia type III; Hypertriglyceridaemia; Low HDL cholesterol
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 07 Apr 2021 New trial record
- 01 Apr 2021 Results published in the European Journal of Clinical Pharmacology